Lara E. Davis

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

Oncology, Pathology, Advanced Soft-tissue Sarcoma +5

Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

Catherine S. Grasso, Yujie Tang, Nathalène Truffaux et al. · Nature Medicine · 2015 · 686 citations · Full text

Neuro-oncology, Therapeutic Targets, Tumor Targeting +6

QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NON-INFLAMMATORY NEUROLOGICAL DISEASE

Melvyn P. Heyes, Kuniaki Saito, Jeffrey S. Crowley et al. · Brain · 1992 · 674 citations

An Oncogenic <i>NTRK</i> Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Robert C. Doebele, Lara E. Davis, Aria Vaishnavi et al. · Cancer Discovery · 2015 · 385 citations · Full text

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

Mrinal M. Gounder, Patrick Schöffski, Robin L. Jones et al. · The Lancet Oncology · 2020 · 383 citations

Tumor Biology, Medicine, Basket Study +8